Ziegeler (2008: 44) identifies root modality with future projecting modality in her study.
Future treatment modalities include molecular targeted therapies.
Understanding them will have an impact on the design of future treatment modalities.
This review intends to bring together prior and current pharmacological interventions and future therapeutic modalities that appear promising in the prevention and management of BPD.
This understanding will potentially yield useful synthetic/modified cannabinergic therapeutic drugs and will very probably serve as future treatment modalities for symptoms of drug withdrawal and addiction.
Finally, current and future treatment modalities for improving tendon healing, such as tissue engineering, cell therapy, and gene therapy, are reviewed.
In this review we will discuss how such pathophysiological mechanisms may lead to the distressing sensory phenomena experienced by patients suffering neuropathic pain, and the relationship of such mechanisms to current and potential future treatment modalities.
This speculation can provide a rationale for the development of future therapeutic modalities aiming to maximize the readthrough potential or to improve the function of the corrected protein at the cell surface.
This model may allow precise evaluation of these future treatment modalities using calcification quantification by imaging.
Future treatment modalities involving biologics and tissue engineering hold further promise to improve outcomes for patients suffering from shoulder pathologies.
